[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

IBEX Ltd (Form 144): A proposed sale of 8,114 common shares is notified for sale on 09/16/2025 through Global Shares Financial Services Inc. The filing reports an aggregate market value of $309,467.96 and lists 13,315,077 shares outstanding for the issuer. The shares were originally acquired on 08/07/2020 as a grant from the issuer. The filer also reported a recent sale of 350 shares on 08/26/2025 generating $10,194.36 in gross proceeds. The notice includes the required representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Positive

• Full disclosure of planned sale including broker, number of shares, and aggregate market value
• Acquisition details provided (acquired 08/07/2020 as a grant from the issuer), aiding transparency
• Recent prior sale disclosed (350 shares on 08/26/2025 for $10,194.36), showing recent trading history
• Attestation included that the seller is not aware of undisclosed material adverse information

Negative

• No contact details completed for filer contact fields in provided content (name, phone, email appear blank)
• Issuer identifying information incomplete in the provided extract (issuer name and address fields are blank in sections shown)

Insights

Securities Analyst

TL;DR: Routine insider sale notice; size appears small relative to total outstanding shares.

The Form 144 documents a proposed sale of 8,114 common shares via a broker, with an aggregate market value reported at $309,467.96. Given the reported 13,315,077 shares outstanding, the sale is a small fraction of the capitalization and is likely a routine liquidity event rather than a control transfer. The filing discloses the shares were acquired as a grant on 08/07/2020 and that a recent smaller sale (350 shares) generated $10,194.36; both details help market participants time and quantify insider selling activity.

Compliance/Risk Analyst

TL;DR: Filing appears compliant and includes the standard attestation about material nonpublic information.

The notice contains the required attestation that the filer does not possess undisclosed material adverse information and identifies the broker and sale date. It lists acquisition details (grant from issuer) and prior sales in the past three months. From a regulatory perspective, the form meets Rule 144 disclosure elements: securities description, acquisition date and nature, broker information, and recent sales. No apparent omissions are visible in the provided fields.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	GLOBAL SHARES FINANCIAL SERVICES INC 575 WASHINGTON BLVD FLOOR 9 JERSEY CITY DC 07310-1616	8114	309467.96	13315077	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/07/2020	GRANT	ISSUER			8114	09/16/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRUCE NEIL DAWSON c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/26/2025	350	10194.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IBEX's Form 144 say about the planned sale of shares?

The filing notifies a proposed sale of 8,114 common shares intended for sale on 09/16/2025 through Global Shares Financial Services Inc.

How much is the aggregate market value of the shares to be sold in the IBEX Form 144?

The filing reports an aggregate market value of $309,467.96 for the 8,114 shares to be sold.

When and how were the shares being sold acquired according to the Form 144?

The shares were acquired on 08/07/2020 as a grant from the issuer.

Did the filer sell any IBEX shares recently before this notice?

Yes. The filing shows a sale of 350 common shares on 08/26/2025 with gross proceeds of $10,194.36.

Does the Form 144 include an attestation about material nonpublic information?

Yes. The filer signs the notice representing they do not know of any material adverse information about the issuer that has not been publicly disclosed.